# Shuimu Biosciences

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/shuimu-biosciences

- Industry: Pharmaceuticals
- Headquarters: Beijing, China
- Website: www.shuimubio.com
- Total disclosed funding: $14M
- Latest round: Angel (Aug 14, 2024)
- Investors on record: 10

## About

Established in 2017 and based in Beijing, China, Shuimu Biosciences Ltd. is a healthcare company that focuses on new drug development. The company's CEO Mr. Chunlong Guo graduated from Tsinghua University, and he was the co-founder of Baihe.com.

The company provides services of Transmission Electron Microscopy, coupled with single particle analysis (Cryo-EM), Microcrystal electron diffraction (Micro-ED), X-ray crystallography, Negative Staining, and Protein Production and Purification. Cryo-EM has become a standard structural technique for the structural determination of proteins and protein complexes. It is a technique to map the interactions between antibodies and antigens and has many applications in antibody development and biologics discovery.

## Funding rounds

- Angel, Aug 14, 2024, $14M — Daotong Investment, Dalton Venture, iFLYTEK, Huashan Capital
- Series A, Sep 8, 2021 — Cowin Capital, SEE Fund, Saifei Investment
- Angel, Mar 7, 2020 — Gaorong Ventures, Puhua Capital, One Capital (China)

## Investors

- Gaorong Ventures (https://capitalatlas.ai/funds/gaorong-ventures) — Angel
- Puhua Capital (https://capitalatlas.ai/funds/puhua-capital) — Angel
- One Capital (China) (https://capitalatlas.ai/funds/one-capital-china) — Angel
- Cowin Capital (https://capitalatlas.ai/funds/cowin-capital) — Series A
- SEE Fund — Series A
- Saifei Investment — Series A
- Daotong Investment — Angel
- Dalton Venture (https://capitalatlas.ai/funds/dalton-venture) — Angel
- iFLYTEK — Angel
- Huashan Capital — Angel